Six of them were upregulated in endometrial cancer patients (CLU, SERPINC1, ITIH4, C1RL, APOC3 and DSC1), while ten were downregulated (APCS, C9, APOA1, ALB, APOA4, CFHR1, ITIH2, and ACTB). Here, ITIH4 is linked to endometrial cancer.